Compounds > trimebutine
Page last updated: 2024-08-16

trimebutine and n-((2,3-dihydro-1,4-benzodioxin-2-yl)methyl)-5-methoxy-1h-indole-3-ethanamine

trimebutine has been researched along with n-((2,3-dihydro-1,4-benzodioxin-2-yl)methyl)-5-methoxy-1h-indole-3-ethanamine in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Dbar, SR; Degterev, DA; Diukova, GM; Indejkina, LK; Makarova, AA; Parfenov, AI; Romashkina, NV; Ruchkina, IN1

Trials

1 trial(s) available for trimebutine and n-((2,3-dihydro-1,4-benzodioxin-2-yl)methyl)-5-methoxy-1h-indole-3-ethanamine

ArticleYear
[Visceral sensitivity in diagnostics and treatment of severe irritated bowel syndrome].
    Terapevticheskii arkhiv, 2022, Sep-05, Volume: 94, Issue:2S

    Topics: Adult; Diarrhea; Duloxetine Hydrochloride; Female; Humans; Irritable Bowel Syndrome; Male; Pain; Serotonin and Noradrenaline Reuptake Inhibitors; Trimebutine

2022